Geographic Variations in the Quality of Oral Anticoagulation With Vitamin K Antagonists in the Era of New Anticoagulants

被引：4
|
作者：
Fauchier, Laurent [1 ]
Taillandier, Sophie [1 ,2 ]
机构：
[1] Ctr Hosp Univ Trousseau, Pole Coeur Thorax Vasc, F-37044 Tours, France
[2] Univ Tours, Fac Med, F-37032 Tours, France
来源：
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2013年 / 2卷 / 01期
关键词：
Editorials; anticoagulant; atrial fibrillation; guideline adherence; NORMALIZED RATIO CONTROL; ATRIAL-FIBRILLATION; STROKE PREVENTION; WARFARIN; COUNTRIES; MORTALITY; THERAPY; CENTERS; RANGE; TIME;
D O I：
10.1161/JAHA.113.000088
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] DIRECT ORAL ANTICOAGULANTS OR VITAMIN K ANTAGONISTS IN AFTER TAVR
    Oliveri, Federico
    Montalto, Claudio
    Tua, Lorenzo
    Lanzillo, Giuseppe
    Compagnoni, Sara
    Fasolino, Alessandro
    Gentile, Francesca Romana
    Ferlini, Marco
    Pepe, Antonella
    Visconti, Luigi Oltrona
    Bongiorno, Andrea
    Leonardi, Sergio
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [22] Direct oral anticoagulants: are they safer than vitamin k antagonists?
    Baumberger, M.
    Hugli, O.
    Buclin, T.
    Livio, F.
    DRUG SAFETY, 2017, 40 (10) : 943 - 944
  • [23] Oral Anticoagulation in Chronic Kidney Disease and Atrial Fibrillation The Use of Non-Vitamin K-Dependent Anticoagulants and Vitamin K Antagonists
    Heine, Gunnar H.
    Brandenburg, Vincent
    Schirmer, Stephan H.
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2018, 115 (17): : 287 - +
  • [24] Are New Oral Anticoagulants Safer Than Vitamin K Antagonists in the Treatment of Venous Thromboembolism?
    Kolinsky, Daniel C.
    Schwarz, Evan S.
    ANNALS OF EMERGENCY MEDICINE, 2016, 67 (04) : 455 - 457
  • [25] New oral anticoagulants versus vitamin K antagonists in countries with good INR control
    Coppens, M.
    NETHERLANDS JOURNAL OF MEDICINE, 2013, 71 (04): : 168 - 169
  • [26] Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users: A Review of Potential Implications
    Camelo-Castillo, Anny
    Rivera-Caravaca, Jose Miguel
    Orenes-Pinero, Esteban
    Ramirez-Macias, Inmaculada
    Roldan, Vanessa
    Lip, Gregory Y. H.
    Marin, Francisco
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 16
  • [27] Pros and Cons of Vitamin K Antagonists and Non-Vitamin K Antagonist Oral Anticoagulants
    Riva, Nicoletta
    Ageno, Walter
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2015, 41 (02): : 178 - 187
  • [28] Patients' adherence to oral anticoagulants therapy: Comparison between vitamin K antagonists and direct oral anticoagulants
    Barcellona, Doris
    Mameli, Antonella
    Cornacchini, Simona
    Perra, Flaminia
    Diovaldi, Marina
    Farci, Nicola
    Moledda, Valentina
    Marongiu, Francesco
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 333 : 162 - 166
  • [29] Anticoagulation quality control in Primary Care with vitamin K antagonists
    Aguirre Rodriguez, Juan Carlos
    Jimenez de la Cruz, Manuel
    Hidalgo Rodriguez, Abraham
    MEDICINA CLINICA, 2017, 148 (12): : 571 - 572
  • [30] Vitamin K antagonists, direct oral anticoagulants, and the rationale for reversal agents
    Gulseth, Michael P.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (10) : S3 - S4
12345